Arcadia Biosciences, Inc. — Director's Dealing 2015

Dec 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2015-12-01

Reporting Person: Knauf Vic C. (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-01	Common Stock	M	6300	$1.08	Acquired	53434	Direct
2015-12-01	Common Stock	S	6300	$3.8889	Disposed	47134	Direct
2015-12-02	Common Stock	M	8700	$1.08	Acquired	55834	Direct
2015-12-02	Common Stock	S	8700	$4.0959	Disposed	47134	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-01	Employee Stock Option (right to buy)	$1.08	M	6300	Disposed	2018-06-30	Common Stock (6300)	Direct
2015-12-02	Employee Stock Option (right to buy)	$1.08	M	8700	Disposed	2018-06-30	Common Stock (8700)	Direct

Footnotes

F1: The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person effective June 12, 2015.

F2: This transaction was executed in multiple trades at prices ranging from $3.78 to $3.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $3.91 to $4.24. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: The option is fully exercisable as of the date hereof.